C.M. Bidwell & Associates »

Amneal Pharmaceuticals shares owned by C.M. Bidwell & Associates

Quarter-by-quarter ownership of Amneal Pharmaceuticals (AMRX) shares owned by C.M. Bidwell & Associates from 13F filings

Historical chart of C.M. Bidwell & Associates investment in Amneal Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Amneal Pharmaceuticals held by C.M. Bidwell & Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Amneal Pharmaceuticals by C.M. Bidwell & Associates

Quarter filed Position value Share count Share price at filing
2025-09-30 $651 65 10.02
2025-06-30 $525 65 8.09
2020-06-30 $141k 30k 4.77

More positions owned by C.M. Bidwell & Associates

Vanguard S&p 500 Etf idx (VOO)
Vanguard Short-Term Bond ETF (BSV)
Vanguard Total Stock Market ETF (VTI)
iShares Russell 2000 Index (IWM)
Vanguard Malvern Fds strm infproidx (VTIP)
iShares Brclys Intrdte Gov/Crt Bd (GVI)
iShares S&P 500 Index (IVV)
Schwab Strategic Tr sht tm us tres (SCHO)
Ishares Tr core strm usbd (ISTB)
iShares MSCI ACWI ex US Index Fund (ACWX)
Vanguard Europe Pacific ETF (VEA)
Vanguard Total Bond Market ETF (BND)
Dimensional Etf Trust (DFAC)
Schwab Strategic Tr 0 (SCHP)
Schwab U S Broad Market ETF (SCHB)

View all positions for C.M. Bidwell & Associates

Top funds holding Amneal Pharmaceuticals

Vanguard Group
BlackRock
Rubric Capital Management
Tpg Gp A
Citadel Advisors
Dimensional Fund Advisors
Nantahala Capital Management
Geode Capital Management
State Street Corporation
Neuberger Berman Group
Millennium Management
Nuveen
Acadian Asset Management
Morgan Stanley
Goldman Sachs Group

View all funds holding Amneal Pharmaceuticals